119 related articles for article (PubMed ID: 38096674)
21. Adherence to guidelines at the patient- and hospital-levels is associated with improved overall survival in patients with gastric cancer.
Kaslow SR; Ma Z; Hani L; Prendergast K; Vitiello G; Lee AY; Berman RS; Goldberg JD; Correa-Gallego C
J Surg Oncol; 2022 Sep; 126(3):479-489. PubMed ID: 35471731
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines.
Stewart SB; Thompson RH; Psutka SP; Cheville JC; Lohse CM; Boorjian SA; Leibovich BC
J Clin Oncol; 2014 Dec; 32(36):4059-65. PubMed ID: 25403213
[TBL] [Abstract][Full Text] [Related]
23. Prereferral head and neck cancer treatment: compliance with national comprehensive cancer network treatment guidelines.
Lewis CM; Hessel AC; Roberts DB; Guo YZ; Holsinger FC; Ginsberg LE; El-Naggar AK; Weber RS
Arch Otolaryngol Head Neck Surg; 2010 Dec; 136(12):1205-11. PubMed ID: 21173369
[TBL] [Abstract][Full Text] [Related]
24. Impact of guideline adherence on patient outcomes in early-stage epithelial ovarian cancer.
Lee JY; Kim TH; Suh DH; Kim JW; Kim HS; Chung HH; Park NH; Song YS; Kang SB
Eur J Surg Oncol; 2015 Apr; 41(4):585-91. PubMed ID: 25624160
[TBL] [Abstract][Full Text] [Related]
25. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer.
Boland GM; Chang GJ; Haynes AB; Chiang YJ; Chagpar R; Xing Y; Hu CY; Feig BW; You YN; Cormier JN
Cancer; 2013 Apr; 119(8):1593-601. PubMed ID: 23280510
[TBL] [Abstract][Full Text] [Related]
26. An evaluation of the utility of computed tomography in high-risk endometrial cancer surveillance.
Lantsman T; Jansen C; Larson E; Esselen K; Shea M
Cancer Treat Res Commun; 2024; 39():100812. PubMed ID: 38582032
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the National Comprehensive Cancer Network and European Society for Medical Oncology Nasopharyngeal Carcinoma Surveillance Guidelines.
Zhou GQ; Lv JW; Tang LL; Mao YP; Guo R; Ma J; Sun Y
Front Oncol; 2020; 10():119. PubMed ID: 32117766
[No Abstract] [Full Text] [Related]
28. Improved guideline compliance and textbook oncologic outcomes among patients undergoing multimodal treatment and minimally invasive surgery for locally advanced gastric cancer.
Rawicz-Pruszyński K; Tsilimigras DI; Endo Y; Munir MM; Katayama E; Benavides JG; Sędłąk K; Pelc Z; Pawlik TM
J Gastrointest Surg; 2024 Jan; 28(1):10-17. PubMed ID: 38353069
[TBL] [Abstract][Full Text] [Related]
29. Adherence with National Comprehensive Cancer Network posttreatment surveillance guidelines in patients with head and neck cancer.
Tam S; Nurgalieva Z; Weber RS; Lewis CM
Head Neck; 2019 Nov; 41(11):3960-3969. PubMed ID: 31497912
[TBL] [Abstract][Full Text] [Related]
30. Same thyroid cancer, different national practice guidelines: When discordant American Thyroid Association and National Comprehensive Cancer Network surgery recommendations are associated with compromised patient outcome.
Adam MA; Goffredo P; Youngwirth L; Scheri RP; Roman SA; Sosa JA
Surgery; 2016 Jan; 159(1):41-50. PubMed ID: 26435426
[TBL] [Abstract][Full Text] [Related]
31. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for laryngeal cancer.
Swegal WC; Herbert RJ; Eisele DW; Chang J; Bristow RE; Gourin CG
Laryngoscope; 2020 Mar; 130(3):672-678. PubMed ID: 31169916
[TBL] [Abstract][Full Text] [Related]
32. Endometrial cancer surveillance adherence reduces utilization and subsequent costs.
Schwartz ZP; Frey MK; Philips S; Curtin JP
Gynecol Oncol; 2017 Sep; 146(3):514-518. PubMed ID: 28734496
[TBL] [Abstract][Full Text] [Related]
33. Suboptimal Compliance With National Comprehensive Cancer Network Melanoma Guidelines: Who Is at Risk?
Blakely AM; Comissiong DS; Vezeridis MP; Miner TJ
Am J Clin Oncol; 2018 Aug; 41(8):754-759. PubMed ID: 28121641
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of Anemia and Compliance With NCCN Guidelines for Evaluation and Treatment of Anemia in Patients With Gynecologic Cancer.
Hufnagel DH; Mehta ST; Ezekwe C; Brown AJ; Beeghly-Fadiel A; Prescott LS
J Natl Compr Canc Netw; 2021 May; 19(5):513-520. PubMed ID: 33524941
[TBL] [Abstract][Full Text] [Related]
35. Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB-IIA Cervical Cancer in California.
Pfaendler KS; Chang J; Ziogas A; Bristow RE; Penner KR
Obstet Gynecol; 2018 May; 131(5):899-908. PubMed ID: 29630020
[TBL] [Abstract][Full Text] [Related]
36. Disparities in ovarian cancer treatment and overall survival according to race: An update.
Huffman DL; Jayakrishnan TT; Shankar K; Peterson CE; Wegner RE
Gynecol Oncol; 2021 Sep; 162(3):674-678. PubMed ID: 34261593
[TBL] [Abstract][Full Text] [Related]
37. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
Bristow RE; Powell MA; Al-Hammadi N; Chen L; Miller JP; Roland PY; Mutch DG; Cliby WA
J Natl Cancer Inst; 2013 Jun; 105(11):823-32. PubMed ID: 23539755
[TBL] [Abstract][Full Text] [Related]
38. Assessing Inequities in Cervical Cancer Quality of Care and Survival Related to Ethnicity and Socioeconomic Factors.
Cantwell CJ; Moroney MR; Sheeder J; Guntupalli SR
J Low Genit Tract Dis; 2021 Jul; 25(3):205-209. PubMed ID: 34050109
[TBL] [Abstract][Full Text] [Related]
39. Colorectal cancer screening in women with endometrial cancer: are we following the guidelines?
Singh MM; Singh E; Miller H; Strum WB; Coyle W
J Gastrointest Cancer; 2012 Jun; 43(2):190-5. PubMed ID: 21380941
[TBL] [Abstract][Full Text] [Related]
40. Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: an NCCN institutional analysis.
Romanus D; Weiser MR; Skibber JM; Ter Veer A; Niland JC; Wilson JL; Rajput A; Wong YN; Benson AB; Shibata S; Schrag D
J Natl Compr Canc Netw; 2009 Sep; 7(8):895-904. PubMed ID: 19755049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
